all down a trajectory of anxiety depression the real reason we're hooked on drugs is because big pharma is essentially stuff in these pills down our throat. and our congressman you know the people we've elect. to look out for our best interests are the ones taking the bribes for instance did you know that in the past decade the pharmaceutical industry has spent more than eight hundred million dollars lobbying congress no other industry spends this much money to sway public policy but it's not enough that big government big pharma are practically in bed together because the other shocking reality is that the same industry spends five billion dollars a year to make sure you and me keep hearing about their wonderful products and they sure do know how to tap into your innermost vulnerabilities don't they. bipolar depression doesn't consume you here's me and here's my depression you know when you feel the weight of sadness you may feel exhausted hopeless and anxious. g. better be careful to not watch those when you're having a bad day you might think you're depressed too and that's exactly w

is it big pharma?ere are a lot of competing interests right now to keep marijuana illegal and unfortunately big farm -- pharma is one of them. important to recognize these concepts are not mutually exclusive. the thought of medical cannabis and cannabis for adult consumption i don't believe there is excuse to continue to put people in prison for cannabis. adam: the reason there is a conspiracy theory, the reason there's a conspiracy theory about this because pharmaceutical companies are petitioning the fda to sell drugs, painkillers in the united states, real thc, the stuff that getting you high, making marijuana worth it. >> indeed. adam: is that what is behind this? >> here's what we know. there are two patents on the medical benefits of cannabis, both neuroprotective and antioxident. that patent is held by the u.s. department of health and human services. so it seems that uncle sam would say, yes, we want to keep marijuana illegal but we will allow one dealer and we're going to go ahead and let that

abbott, pharma, good yields in all these, good growth, tobacco, retailer, pharma, bank, telco. winner tonight. stay with cramer. greetings from the windy city of chicago. people here sure are friendly but some have had a hard time understanding my accent. so to make sure people get every word of the geico savings message i've been practicing how to talk like a true chicagoan. switching to geico could save you hundreds of dollars on car insurance... da bears. haha... you people sure do talk funny. geico®. fifteen minutes could save you fifteen percent or more on car insurance. >> everybody's exciting about research in motion because they didn't report such a horrible number.

abbott, pharma, good yields in all these, good growth, tobacco, retailer, pharma, bank, telco.'s portfolio is the winner tonight. stay with cramer. now, that's what i call a test drive. silverado! the most dependable, longest lasting, full-size pickups on the road. so, what do you think? [ engine revs ] i'll take it. [ male announcer ] it's chevy truck month. now during chevy truck month, get 0% apr financing for 60 months or trade up to get the 2012 chevy silverado all-star edition with a total value of $8,000. hurry in before they're all gone! in absolute perfect iphysical conditioner, and i had a heart attack right out of the clear blue... i'm on an aspirin regimen... and i take bayer chewables. [ male announcer ] be sure to talk to your doctor before you begin an aspirin regimen. he's my success story. [ laughs ] >> everybody's exciting about research in motion because they didn't report such a horrible number. there's always a bull market somewhere and i promise to try to find it somewhere for you. to find it somewhere for you. i will see you tomorrow. patients and insuran

abbott, pharma, good yeelgds in all these, good growth, tobacco, retailer, pharma, bank, telco. that is, they tan's portfolio is the winner tonight. stay with cramer. you know what i love about this country? trick question. i love everything about this country! including prilosec otc. you know one pill each morning treats your frequent heartburn so you can enjoy all this great land of ours has to offer like demolition derbies. and drive thru weddings. so if you're one of those people who gets heartburn and then treats day after day, block the acid with prilosec otc and don't get heartburn in the first place. [ male announcer ] one pill each morning. 24 hours. zero heartburn. humans -- sometimes life trips us up. and sometimes, we trip ourselves up, but that's okay. at liberty mutual insurance we can "untrip" you as you go through your life with personalized policies and discounts when you need them most. just call... and speak with a licensed representative about saving on your policy when you get married, move into a new house... [crash!] or add a car to your policy. don't forg

very much an effort on the part of a number of constituencies, including academic institutions, the pharma institutions as well as the patient themselves who are willing to put themselves in clinical trials. >> part of the question is there a way to confuse the clinical trial enterprise with more of a sense of urgency as mike mentioned with the h.i.v. , to get things done more quickly? >> well, i think that's a huge point that you make, that we need to find that out. in clinical trials, you know, it is a very complicated process, the number of people and stakeholders involved in that process. we need to have patients that trust us, are willing to enter into clinical trials. we need insurance companies that are willing to make it easier for us to decide what's paid for by the sponsor, what's paid for by the insurance companies for the associated care within it. we need doctors that are aware of and ready to put their energy into it. so it goes across the board in terms of where >>> next, some final thoughts from our panel on science in an age of austerity. >>> now in its 20th year, visit bi

isis pharma, i think it's headed to close to the sun. presenting at 1:30 p.m.dnesday, a unique story. the stock is up 100% year to date. no matter how good this sounds tomorrow, if you buy it up here you are chasing. we never chase on that money. same goes with two that present tomorrow at 9:00. who says you can't make money in the stock markets? the stocks are too hot to handle and i think if you try to touch them now you can get singed, if not burned. out of the solar biotechs does that mean we can't have anything that we like? no, we're going to hear from someone i like very much. my favorite speculation name at this whole shindig is nps pharmaceuticals. this company's presentation is at 9 am tomorrow and i certainly recommend you listen to what they have to say. unlike the others i just mentioned they are not much of a highflyer. 8 oller and change stock on not only up 25%. two working with drugs for short bowel syndrome and hyper parathyroid is him. orphan drug street diseases that affect a short number of people. that government gives companies that make

some of the pharma names. we saw the nyse acca pharma index hit a ten-day high. some big movers, pfizer, novartis, lily. >> thank you. we have much more ahead on the "closing bell." >> announcer: would you be willing to receive less from social security to help fix the nation's financial problems? that's what mitt romney is proposing. >> people with higher incomes won't get the same high growth rate in their benefits than people with lower incomes. >> announcer: is it time for americans to pay up for entitlements and will that end up costing him votes in november? plus, which defense companies will get hit the hardest if congress isn't able to avoid billions in spending cuts? details are ahead. and is it possible to solve global poverty and be prosperous at the same time? the head of one venture capitalist thinks so. the equity summary score consolidates the ratings of up to 10 independent research providers into a single score that's weighted based on how accurate they've been in the past. i'm howard spielberg of fidelity investments. the equity summary score is

that's one of the reasons the money managers are allocating capital into pharma. bristol yielding 4%. merck yielding 3.8. regardless of the broader economy, j&j is at an inflection point in terms of earnings growth. they expect j&j to transfer 2% to 3% revenue growth to 4% to 5%. so j&j is one stock to watch. >> let's turn to courtney and a sector i like to spend time with, retail. >> it's going to be an important season coming up. may not seem there's an obvious correlation between foreign policy and retail. after speaking to some analysts, a number believe it's the higher end retailers that will likely feel the positive impacts from further quantitative easing while the middle retailers could be further squeezed. morning star's paul swinton said it pushed the money into commodities, which actually end up hurting department stores on the cost side. notice it didn't do kohl's any favors. but global luxury companies seem to benefit when the go-go entrepreneurs of emerging markets are suddenly flush with cash. they want to do luxury goods shopping. jp morgan's big b

i think that takeover bid starts to show up in some of those smaller cap pharma names.r, it's been a market that's primarily been driven by mega caps over the last number of months. fact that small cap health care is working just as well as big cap health care, i think is pretty encouraging for the entire space. that's why i bring up that point that the equally weighted health care index is also at new highs. that's an important distinction to make. that participants and breadth has been very good throughout this move. >> chris, thanks for stopping by. >>> i would call glaxo an emerging market company. these stocks are going also -- they're almost becoming growth plays even though their valuations are dropping. the reason why these have become so popular in the last couple years which i think have spurred this breakout, the dividend yields. this is like owning an annuity and these guys are delivering that and they are spinning off cash and they have patents that are running out and they're selling them down the chain to some smaller guys. >> things for pms, the charts h

toll booth so whether it's the toll booth operated by big agriculture the tollbooth operated by big pharma or the finance industrial complex or the military industrial complex if you. have a problem with their toll booth then basically you go to guantanamo as you have told open with them told books to pay for the told with operator for example and grace grace is now big tall both because the i.m.f. and the troika did a leveraged buyout they loaded up with debt now they own the country now it's a big cold with everyone living in greece oh by the way they're dying in the streets.

toll booth so whether it's the toll booth operated by big agriculture the toll booth operated by big pharma or the finance industrial complex or the military industrial complex if you have a problem with their toll booth then basically you go to guantanamo and you have told both opening within told books to pay for the told would operate or for example and grace grace is now big tall both because the i.m.f. and the troika did a leveraged buyout they loaded up with debt now they own the country now it's a big cold with everyone living in greece obama would have died in the streets thank you i am so thank you chris you can go to thank you barack obama you are committing murder to many destinations the economic oppression it also called off thank you so much well the word of the day is banks the cocher see and that is that a piece of art here by the very suspicious billion pounds i seven as you see on the left that's a banking system gorging itself on a giant meal served by the government butler on the right is the people eating a bone and wearing very tattered clothing thanks to talk the bank

the real causes of skyrocketing costs which may rock the boats of some major lobbies such as big pharma or big insurance or trial lawyers let's take one example just to point out so according to a recent report from the institute of medicine the systemic waste within the u.s. health care system is a staggering seven hundred sixty five billion dollars this represents thirty percent of total expenditures for some perspective now the report claims that two hundred ten billion dollars of that are wasted in unnecessary procedures that tops a list of other things you can see such as access it ministry of cost so as far as unnecessary procedures it says money's being wasted but that doesn't give insight into why physicians we've spoken to say sure there are bad doctors as much as there are bad seeds in any profession for example doctors that claiming condo or excuse me for example claiming that doctors what happened here i just spent this out so essentially there are bad seeds sure but one thing that doctors cite is malpractise risks and malpractise suits and defensive medicine that they need

pharma managers confirm that is where he died. he was the long shot when he won back in 1983 by a head. the track was muddy which made the victory even more exciting and shocking for spectators. he spent his last years at the farm rusting and reading more than two dozen top running horses. >> an alarming report on obesity rates in america. numbers are expected to skyrocket by 2030 with 39 states now expecting to have an obesity rate of greater than 50%. we are ranked 22 nationwide when it comes to of the city. more than 28% of the adult population is considered obese. now i knew report is raising concerns. erica edwards explains. >> canned goods are often a go- to foods for busy parents trying to get a meal on the table quickly. a chemical used to prevent corrosion in the lining, may benol a, or bpa making children that. >> we were surprised the association was so strong. >> they lead a study that found kids with the highest concentrations in the systems were twice as likely to be obese. >> defect was found only in white children

. -- big pharma. this is the new elite. they are the new land owners, they are controlling power. they will schiff washington, d.c. i do not think are bad but they're not good. they are not improving the world. google has not benefited the world. facebook has not benefited the world. generally i am very suspicious of the idiot that you can do good and be very rich at the same time. or successful. >> let me read some more things from your book. even about the narcissism in -- and exoduses and -- and exhibitionism of facebook. we do have one -- we do have some facebook representative in the audience. >> can you reveal yourself, please? -- we do have some representatives in the audience. >> can you reveal yourself, please? all your data. everything about you. can we have a time line? [laughter] >> there is a bit of hypocrisy on your part. you listed on your blog where you're going to be every day, almost every hour. put your twitter screenname on the cover of your book. you're writing by your trips to london and your experiences there. isn't this exhibitionist? >> i grew up a in engl

medical es the et ticks and specialty pharma play that's one of the fastest growing drug companies aroundox, breast implants, eyelash enlargers. it is not just a vanity play. there is a medical side with a big eye care business where they treat dry eye to glaucoma. my favorite thing is they keep coming up with new uses with old products. for example, they turned botox into a treatment for migraines. plus, allergan has a terrific pipeline. however the bears are worried the revenue growth may be slowing because of increased competition and the valuation. the stock is selling for 18.7 times next year's earnings. i like the issue a lot. i'm thrilled to have the chair man and ceo here on set tonight to talk about how the company is doing and where it is headed. welcome back. >> thank you, jim. thanks for having me. >> out's a funny thing. everyone says it was a terrific quarter, but you guys were the ones, i felt, that were very humble about the quarter. talk about how you were willing -- i mean certainly mr. edwards was to say we had head winds that made it so we weren't able to do what we wa

don't get me wrong, i still think that bristol-myers is the best growth story in big pharma and it's a glorious 4.1% yield, bought the stock when the stock got hit. but it's no longer the best way to play hepatitis. after bristol-myers dropped out of the race, the fda also halted testing of another drug. based on similar side effects, that was enough to knock that one off. the main ones are abbott labs, merck, j & j. those are huge drug companies and these drugs might be too small versus the overall size of the companies. vertex has something. their pipeline is too early and there's limited data. that leaves us with two more ponies, highly risky and highly speculative killion. i'm picking gilead tonight. gilead is the way. not only the last man standing, the hepatitis c drug they're developing comes from the same family as drugs bristol-myers were working on except without the harmful side effects. the bad news for the other two players, listen, it's fabulous for gilead. that's one small piece of the puzzle. they've built into a truly incredible biotech franchise. the number one port

for instance, his willingness to play ball with pharma made the bill cost a lot more than it need. >> the pharmaceutical industry? >> yes. that said, he was legitimately elected. we were in a very, very serious situation in this country. if the economy had fallen any further, it would be comparable to the great depression. so what is minority leader mitch mcconnell in the senate, what is his first priority for the country? is it getting jobs for people? is it restoring the solvency of the financial system? is it foreign policy? is it any of those things? no, it's making sure obama is a one-term president. >> it seems that some of these people are willing to see the government go down in order to win. >> that would be the case. i grew up in a party that believed in the traditions of eisenhower, and for that matter, even reagan. he raised taxes several times when the deficit threatened to get out of control. he pleaded with congress to send him a clean debt limit extension bill, without any extraneous riders on it. he knew what the stakes were. but now it's basically obstruct. they're n

i spend a lot of time speaking with heads of r&d and pharma about things that are getting in their way that are actually competitive that nih can play a bigger role in. age example is this effort to identify the right targets for the next generation of drug development. we have a whole long list of potential targets that are coming out of genomics but most people aren't quite sure which ones to invest in. like the list is too big. so how do we develop the right filter? working with industry in a series of workshops and now what's increasingly likely to be a collaborative plan we hope to be able to do that more systematically in a way where everiable has access to the information but industry can decide how to place their bets. another example recently developed a program with industry where eight companies have agreed to make available 58 compounds that have already been in humans in clinical trials but which are not currently being pursued because of lack of efficacy or because the company changed their business plan. they are now being made available and crowd sourcing them to academ

because we went into wars and didn't pay for them, because we have big pharma. are you willing as a millionaire to do more for the country? that's what this election is about. and romney has got a plan that's not going to ask the wealthiest americans to do more. that's it the difference. romney's attempt to reset his campaign didn't get very far with the "60 minutes" interview and his answers on tax fairness. richard wolf and dean baker will join me next. stay with us. >>> coming up, mitt romney says he has paid his fair share of tax. but can he convince voters? richard wolffe and dean baker will weigh in next. >>> newt gingrich, he's back at it. joins todd akin on the campaign trail and says mitt will change his mind. about supporting this candidate. i'll ask howard fineman how long the republican party will go, how far they will go to try to win the senate. >>> and romney says the uninsured can rely on emergency rooms for health care. but five years ago, he called the same practice socialism. we'll have the details. share your thoughts with us on facebook and

this relay race between academe yeah, biotech and pharma is one with a very significant rate of failure and the targets for emphasis may not be the ones that the public needs, namely in prevention and early detection, but in drug development itself, there's a 95% failure rate in cancer drug development in part because we're not from the academic level moving the ball down the field enough and have the launch point into the private sector be more mature, so as a result we bring many things into the clinic through this relay race that ends up failing. so what we want to do at m.d. anderson is to harness a new organizational construct that has the combination of academic creativity and scholarship, but also that industry-like execution capability that allows us to ensure that discoveries reach these clinical end points, so that's a distinguishing feature of this moon shot which is to have us bring it forward into this more action-oriented, goal-oriented kind of construct. >> where are you seeing the most innovation right now in terms of companies and moving the needle on this? are you seei